Oil declines on restart of pipelines shut by US Midwest ice storm

December 12, 2007 07:10


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


Oil prices dropped Wednesday in Asia on reports pipelines shut by an ice storm in the US Midwest had been restarted, and after the Federal Reserve cut a key interest rate less than many had hoped. An ice storm that caused outages of key US oil pipelines helped drive oil prices up by more than $2 a barrel in the previous session. But Dow Jones Newswires reported that at least one of the pipelines - some of which serve the closely watched New York Mercantile Exchange delivery terminal at Cushing, Oklahoma - had been quickly restarted and that three others would soon follow. Light, sweet crude oil for January delivery fell 65 cents to $89.37 a barrel in Asian electronic trading on the Nymex by midday in Singapore. The contract rose $2.16 to settle at $90.02 a barrel Tuesday.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection


Cookie Settings